Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koenen, H. J. P. M.
Right arrow Articles by Joosten, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenen, H. J. P. M.
Right arrow Articles by Joosten, I.
Related Collections
Right arrow Transplantation
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 10 (May 15), 2000: pp. 3153-3161

Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness

Hans J. P. M. Koenen and Irma Joosten

From the Department for Blood Transfusion and Transplantation Immunology, University Medical Center, St Radboud, Nijmegen, The Netherlands.

The generation of immunoregulatory T cells that block the B7(CD86/CD80)-CD28 and/or CD40-CD154 costimulatory pathways has great potential for the induction of long-term transplantation tolerance. In a human polyclonal in vitro model, combined monoclonal antibody (mAb) blocking of the costimulatory ligands CD40 and CD86 lead to allospecific T-cell anergy that cannot be reversed by antigenic rechallenge in the presence of IL-2. Although antigenic restimulation with IL-2 restored the proliferative response, subsequent antigenic restimulation of the restored anergic cells in a tertiary mixed lymphocyte culture still resulted in nonresponsiveness. Importantly, these anergic T cells suppress the response of naive alloreactive T cells in an antigen-specific way via linked recognition. Suppression may partially depend on local IL-10 production, while transforming growth factor-beta (TGF-beta ) did not play a role. Irrespective of the monoclonal antibody combination used, blast formation occurred in a subset of CD4+ cells. These cells were characterized by a sustained CD45RA expression, an increased T-cell receptor density, and a lower level of CD4 expression. A reduced number of CD45RO+/CD8+ T cells was observed whenever anti-CD86 was combined with anti-CD40, which was reflected by an even more attenuated cytotoxic T-cell function. This indicates the importance of CD40-CD154 in the generation of cytotoxic T cells in this transplantation model. We hypothesize that in our model, anergy is induced in the CD4+ T-cell subset, whereby CD8+ cytotoxic effector function is impaired by the lack of both CD40-CD154 signaling and cytokine-mediated help. This costimulatory ligand-directed mAb approach might well be used for the ex vivo generation of antigen-specific immunoregulatory T cells applicable in adoptive immunotherapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. J. A. Coenen, H. J. P. M. Koenen, E. van Rijssen, L. Boon, I. Joosten, and L. B. Hilbrands
CTLA-4 Engagement and Regulatory CD4+CD25+ T Cells Independently Control CD8+-Mediated Responses under Costimulation Blockade
J. Immunol., May 1, 2006; 176(9): 5240 - 5246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Mayerova, L. Wang, L. S. Bursch, and K. A. Hogquist
Conditioning of langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo.
J. Immunol., April 15, 2006; 176(8): 4658 - 4665.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Yadav, V. Judkowski, M. Flodstrom-Tullberg, L. Sterling, W. L. Redmond, L. Sherman, and N. Sarvetnick
B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets
J. Immunol., September 15, 2004; 173(6): 3631 - 3639.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Vigouroux, E. Yvon, E. Biagi, and M. K. Brenner
Antigen-induced regulatory T cells
Blood, July 1, 2004; 104(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Vermeiren, J. L. Ceuppens, M. Van Ghelue, P. Witters, D. Bullens, H. W. Mages, R. A. Kroczek, and S. W. Van Gool
Human T Cell Activation by Costimulatory Signal-Deficient Allogeneic Cells Induces Inducible Costimulator-Expressing Anergic T Cells with Regulatory Cell Activity
J. Immunol., May 1, 2004; 172(9): 5371 - 5378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. J. P. M. Koenen, E. Fasse, and I. Joosten
IL-15 and Cognate Antigen Successfully Expand De Novo-Induced Human Antigen-Specific Regulatory CD4+ T Cells That Require Antigen-Specific Activation for Suppression
J. Immunol., December 15, 2003; 171(12): 6431 - 6441.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Admyre, J. Grunewald, J. Thyberg, S. Gripenback, G. Tornling, A. Eklund, A. Scheynius, and S. Gabrielsson
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid
Eur. Respir. J., October 1, 2003; 22(4): 578 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Giuliani, C. G. Goodyer, J. P. Antel, and V. W. Yong
Vulnerability of Human Neurons to T Cell-Mediated Cytotoxicity
J. Immunol., July 1, 2003; 171(1): 368 - 379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Elhalel, J.-H. Huang, W. Schmidt, J. Rachmilewitz, and M. L. Tykocinski
CTLA-4 {middle dot} FasL Induces Alloantigen-Specific Hyporesponsiveness
J. Immunol., June 15, 2003; 170(12): 5842 - 5850.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Guillot, S. Menoret, C. Guillonneau, C. Braudeau, M. G. Castro, P. Lowenstein, and I. Anegon
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig
Blood, April 15, 2003; 101(8): 3325 - 3333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Wakkach, F. Cottrez, and H. Groux
Differentiation of Regulatory T Cells 1 Is Induced by CD2 Costimulation
J. Immunol., September 15, 2001; 167(6): 3107 - 3113.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Rossi, J. Sarkar, and D. Scandella
Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A
Blood, May 1, 2001; 97(9): 2750 - 2757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. S. Lee, J. R. Rusche, M. E. Maloney, D. H. Sachs, M. H. Sayegh, and J. C. Madsen
CTLA4Ig-Induced Linked Regulation of Allogeneic T Cell Responses
J. Immunol., February 1, 2001; 166(3): 1572 - 1582.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020